LU86875A1 - Utilisation de l'activateur tissulaire du plasminogene,son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association - Google Patents
Utilisation de l'activateur tissulaire du plasminogene,son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association Download PDFInfo
- Publication number
- LU86875A1 LU86875A1 LU86875A LU86875A LU86875A1 LU 86875 A1 LU86875 A1 LU 86875A1 LU 86875 A LU86875 A LU 86875A LU 86875 A LU86875 A LU 86875A LU 86875 A1 LU86875 A1 LU 86875A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- gly
- ser
- leu
- arg
- cys
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86204686A | 1986-05-12 | 1986-05-12 | |
US06/862,057 US4976959A (en) | 1986-05-12 | 1986-05-12 | T-PA and SOD in limiting tissue damage |
US86205786 | 1986-05-12 | ||
US86204686 | 1986-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU86875A1 true LU86875A1 (fr) | 1988-01-20 |
Family
ID=27127662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU86875A LU86875A1 (fr) | 1986-05-12 | 1987-05-11 | Utilisation de l'activateur tissulaire du plasminogene,son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPH0680015B2 (ja) |
AU (1) | AU600724B2 (ja) |
BE (1) | BE1001425A4 (ja) |
CH (1) | CH672989A5 (ja) |
DE (1) | DE3715662A1 (ja) |
DK (1) | DK237187A (ja) |
FR (1) | FR2600895B1 (ja) |
GB (1) | GB2194886B (ja) |
IE (1) | IE59895B1 (ja) |
LU (1) | LU86875A1 (ja) |
NL (1) | NL8701113A (ja) |
NZ (1) | NZ220260A (ja) |
SE (1) | SE8701921L (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0780784B2 (ja) * | 1987-10-23 | 1995-08-30 | 宇部興産株式会社 | 微小循環障害に基づく心筋虚血傷害治療薬 |
NZ230808A (en) * | 1988-10-24 | 1993-04-28 | Squibb & Sons Inc | Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent |
DE4038563A1 (de) * | 1990-12-04 | 1992-06-11 | Gruenenthal Gmbh | Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma |
DE19518625C2 (de) * | 1995-05-24 | 1997-08-07 | Buescher Pebueso Beton | Verfahren zum Abdichten von Betonrohren und ein für die Durchführung des Verfahrens geeignetes Betonrohr |
US8680059B2 (en) | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
US7175679B2 (en) | 2001-03-29 | 2007-02-13 | Biotempt B.V. | Oligopeptide treatment of NF-κB mediated inflammation |
EP1138692A1 (en) | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
US6844315B2 (en) | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US6921751B1 (en) | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
EP1300418A1 (en) | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
US7576174B2 (en) | 2000-03-29 | 2009-08-18 | Biotempt B.V. | Compositions capable of reducing elevated blood urea concentration |
US7501391B2 (en) | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
US7786084B2 (en) | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US7517529B2 (en) | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
JP4846799B2 (ja) | 2005-07-05 | 2011-12-28 | バイオテンプト ベー.フェー. | 腫瘍の治療 |
EP1864692A1 (en) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
US8652476B2 (en) | 2009-07-27 | 2014-02-18 | Niigata University | Pharmaceutical composition for treating ischemic events |
WO2011013668A1 (ja) * | 2009-07-27 | 2011-02-03 | 国立大学法人新潟大学 | 虚血性イベントの治療用医薬品組成物 |
US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8003402A (nl) * | 1980-06-11 | 1982-01-04 | Leuven Res & Dev Vzw | Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking. |
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
JPS59196824A (ja) * | 1983-04-21 | 1984-11-08 | Kowa Co | 吸着防止剤 |
US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
NL8601354A (nl) * | 1985-05-28 | 1986-12-16 | Wellcome Found | Nieuwe samenstelling. |
WO1987006831A1 (en) * | 1986-05-15 | 1987-11-19 | Emory University | Composition and method for treating a thrombus and embolus |
-
1987
- 1987-05-11 DK DK237187A patent/DK237187A/da not_active Application Discontinuation
- 1987-05-11 NZ NZ220260A patent/NZ220260A/xx unknown
- 1987-05-11 FR FR8706551A patent/FR2600895B1/fr not_active Expired - Lifetime
- 1987-05-11 CH CH1788/87A patent/CH672989A5/de not_active IP Right Cessation
- 1987-05-11 AU AU72704/87A patent/AU600724B2/en not_active Ceased
- 1987-05-11 IE IE121087A patent/IE59895B1/en not_active IP Right Cessation
- 1987-05-11 BE BE8700510A patent/BE1001425A4/fr not_active IP Right Cessation
- 1987-05-11 JP JP62114386A patent/JPH0680015B2/ja not_active Expired - Lifetime
- 1987-05-11 DE DE19873715662 patent/DE3715662A1/de active Granted
- 1987-05-11 SE SE8701921A patent/SE8701921L/xx unknown
- 1987-05-11 NL NL8701113A patent/NL8701113A/nl not_active Application Discontinuation
- 1987-05-11 LU LU86875A patent/LU86875A1/fr unknown
- 1987-05-11 GB GB8711058A patent/GB2194886B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0680015B2 (ja) | 1994-10-12 |
FR2600895A1 (fr) | 1988-01-08 |
BE1001425A4 (fr) | 1989-10-31 |
IE59895B1 (en) | 1994-04-20 |
FR2600895B1 (fr) | 1993-12-24 |
GB8711058D0 (en) | 1987-06-17 |
NL8701113A (nl) | 1987-12-01 |
IE871210L (en) | 1987-11-12 |
DE3715662A1 (de) | 1987-11-19 |
AU600724B2 (en) | 1990-08-23 |
JPS6322026A (ja) | 1988-01-29 |
NZ220260A (en) | 1990-07-26 |
DK237187D0 (da) | 1987-05-11 |
DK237187A (da) | 1987-11-13 |
SE8701921D0 (sv) | 1987-05-11 |
GB2194886B (en) | 1990-04-25 |
GB2194886A (en) | 1988-03-23 |
AU7270487A (en) | 1987-11-19 |
CH672989A5 (ja) | 1990-01-31 |
SE8701921L (sv) | 1987-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE1001425A4 (fr) | Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association. | |
AU607303B2 (en) | Composition of anticoagulants | |
EP0115974B1 (fr) | Préparation à activité collagénolytique ayant une activité élevée et compositions pharmaceutiques la contenant | |
FR2593393A1 (fr) | Solution aqueuse a usage parenteral d'activateur tissulaire du plasminogene, procede pour la preparer et recipient obture la contenant | |
LU86444A1 (fr) | Nouvelle compostion d'activateur tissulaire du plasminogene | |
HU224826B1 (en) | Activated protein c formulations | |
FR2591485A1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
US4976959A (en) | T-PA and SOD in limiting tissue damage | |
EP2268267B1 (en) | Dry transglutaminase composition | |
US20110053851A1 (en) | Haemostasis-modulating compositions and uses therefor | |
EP0357296A1 (en) | Combination of t-PA and protein C | |
FR2634125A1 (fr) | Composition pharmaceutique a base de superoxyde dismutase | |
TW200529870A (en) | Therapeutic use of factor XI | |
CA1282002C (en) | Pharmaceutical composition comprising t-pa and oxypurinol | |
JP2916947B2 (ja) | Cpb―iの安定化方法及び製剤組成物 | |
JP3227673B2 (ja) | 膵炎予防治療薬 | |
CN1320922C (zh) | 基于用丙二烯氧合酶将脂质过氧化物酶消除的心脏保护疗法 | |
FR2605225A1 (fr) | Compositions pharmaceutiques a base d'urokinase | |
FR2495634A1 (fr) | Enzyme nouvelle et utilisable en therapeutique | |
JPH05368B2 (ja) | ||
JPH09143092A (ja) | 心筋梗塞予防治療剤 | |
FR2538702A1 (fr) | Preparation a activite collagenolytique ayant une activite elevee et compositions phamaceutiques la contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DT | Application date | ||
TA | Annual fee |